Intensity-Modulated Radiation Therapy with Concurrent Carboplatin and Paclitaxel for Locally Advanced Head and Neck Cancer: Toxicities and Efficacy

Ítems similars

• A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer
  per: Vlacich, Gregory, et al.
  Publicat: (2017)
• nab-Paclitaxel in Combination With Weekly Carboplatin With Concurrent Radiotherapy in Stage III Non-Small Cell Lung Cancer
  per: Lammers, Philip Edward, et al.
  Publicat: (2015)
• Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
  per: Haddad, R.I., et al.
  Publicat: (2019)
• Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
  per: Machtay, Mitchell, et al.
  Publicat: (2008)
• Nodal Volume Reduction after Concurrent Chemo- and Radiotherapy: Correlation between Initial CT and Histopathologic Findings
  per: Labadie, Robert F., et al.
  Publicat: (2000)